BAD THINGS AFOOT
Previously, BPMX stated they were meeting with the FDA for P3 this Summer, I wont go as far as to say by when but I am going back through my saved evidence to see.
In their latest news release and statements they PLAN to meet with the FDA on P3... STILL.
These delays ARE NOT GOOD.
Something is fundamentally wrong here.
FOMX and DERM are way out in front on all of this and BPMX has no money and severely discounted the retail on the last HELP US KEEP THE LIGHTS ON OVER THE SUMMER mini offering.
A 20 to 30 % discount on retail for a mega p3 funding offering places this at 20 to 24 cents per share as of today.
Also keep in mind that FOMX failed P3 the first time, and BPMX missed secondary on P2. A P3 failure on BPMX,,, that will be catastrophic,, and right now the ability of management to MANAGE is looking IFFY.
Caveat Emptor
